Retatrutide is an investigational compound developed by Eli Lilly. It belongs to a new class of multi-receptor agonists being studied for their potential to improve weight management and metabolic health. Early clinical studies suggest promising results in obesity and related metabolic disorders, though the medication is not yet approved for general medical use. https://bestchemslab.com/product/retatrutide-10-mg/